DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Seymour JF, Kipps TJ, Eichhorst B. et al.
Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
N Engl J Med 2018;
378: 1107-1120
We do not assume any responsibility for the contents of the web pages of other providers.